TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, ...
MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF ...
Operating through 130 Company-operated treatment centers, Greenbrook is a leading provider of TMS and Spravato® (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Greenbrook Tms ( (GBNHF)) has ...
TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, ...
MALVERN, Pa. and TORONTO, Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (GBNHF) ("Greenbrook") today announced ...
TORONTO, June 5, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") announced today that the sellers of Check Five LLC (d/b/a "Success TMS") ("Success TMS") have ...
Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Greenbrook Tms (GBNH – Research Report) today. The company’s shares opened today at $1.01. According to TipRanks, Keywood is a 4-star ...
TORONTO, ON , June 23, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United ...
Greenbrook TMS of Missouri offers compassionate care to thousands needing mental health support. We provide TMS, esketamine nasal spray, talk therapy, and medication management. Taking the first step ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback